Endurant Capital Management as of Sept. 30, 2022
Portfolio Holdings for Endurant Capital Management
Endurant Capital Management holds 49 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Invacare Corp Note 5.000%11/1 | 16.0 | $49M | 57M | 0.86 | |
| Laboratory Corp Amer Hldgs Com New (LH) | 6.5 | $20M | 97k | 204.81 | |
| Humana (HUM) | 5.2 | $16M | 33k | 485.20 | |
| Takeda Pharmaceutical Sponsored Ads (TAK) | 4.7 | $14M | 1.1M | 12.97 | |
| Baxter International (BAX) | 4.3 | $13M | 245k | 53.86 | |
| Qiagen Nv Shs New | 4.1 | $13M | 304k | 41.28 | |
| Eli Lilly & Co. (LLY) | 4.0 | $12M | 38k | 323.35 | |
| BioMarin Pharmaceutical (BMRN) | 4.0 | $12M | 145k | 84.77 | |
| Icon SHS (ICLR) | 4.0 | $12M | 66k | 183.78 | |
| Bristol Myers Squibb (BMY) | 3.7 | $11M | 159k | 71.09 | |
| Catalent (CTLT) | 3.3 | $10M | 140k | 72.36 | |
| Cigna Corp (CI) | 3.1 | $9.5M | 34k | 277.46 | |
| Omega Healthcare Investors (OHI) | 3.0 | $9.3M | 314k | 29.49 | |
| Invacare Corp Note 5.000%11/1 | 2.7 | $8.4M | 10M | 0.84 | |
| Aziyo Biologics Cl A Com (ELUT) | 2.7 | $8.2M | 1.1M | 7.20 | |
| Becton, Dickinson and (BDX) | 2.5 | $7.6M | 34k | 222.83 | |
| Anthem (ELV) | 2.4 | $7.4M | 16k | 454.21 | |
| Zoetis Cl A (ZTS) | 2.1 | $6.6M | 44k | 148.29 | |
| Selecta Biosciences (RNAC) | 2.1 | $6.5M | 3.9M | 1.64 | |
| Astrazeneca Sponsored Adr (AZN) | 1.8 | $5.5M | 101k | 54.84 | |
| McKesson Corporation (MCK) | 1.8 | $5.5M | 16k | 339.87 | |
| Ocular Therapeutix (OCUL) | 1.4 | $4.4M | 1.1M | 4.15 | |
| Encompass Health Corp (EHC) | 1.2 | $3.8M | 83k | 45.23 | |
| Tenet Healthcare Corp Com New (THC) | 1.2 | $3.6M | 71k | 51.58 | |
| Ventas (VTR) | 1.1 | $3.4M | 86k | 40.17 | |
| Albireo Pharma | 1.1 | $3.3M | 173k | 19.36 | |
| Bio Rad Labs Cl A (BIO) | 0.9 | $2.9M | 7.0k | 417.10 | |
| Merit Medical Systems (MMSI) | 0.9 | $2.9M | 51k | 56.50 | |
| Arcus Biosciences Incorporated (RCUS) | 0.8 | $2.5M | 97k | 26.16 | |
| Insmed Com Par $.01 (INSM) | 0.8 | $2.3M | 108k | 21.54 | |
| Galapagos Nv Spon Adr (GLPG) | 0.7 | $2.2M | 51k | 42.64 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.6 | $1.9M | 1.8M | 1.08 | |
| Cano Health Com Cl A | 0.6 | $1.8M | 211k | 8.67 | |
| Veracyte (VCYT) | 0.6 | $1.8M | 109k | 16.60 | |
| Avantor (AVTR) | 0.5 | $1.5M | 76k | 19.61 | |
| Sutro Biopharma (STRO) | 0.5 | $1.5M | 267k | 5.55 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.5 | $1.4M | 179k | 8.07 | |
| Option Care Health Com New (OPCH) | 0.4 | $1.4M | 44k | 31.48 | |
| Owens & Minor (OMI) | 0.4 | $1.3M | 56k | 24.11 | |
| Vaxcyte (PCVX) | 0.4 | $1.3M | 52k | 23.99 | |
| Reata Pharmaceuticals Cl A | 0.2 | $612k | 24k | 25.13 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.2 | $580k | 23k | 25.54 | |
| Acumen Pharmaceuticals (ABOS) | 0.2 | $555k | 55k | 10.03 | |
| Mirati Therapeutics | 0.2 | $553k | 7.9k | 69.87 | |
| Relmada Therapeutics (RLMD) | 0.2 | $524k | 14k | 37.04 | |
| Cytokinetics Com New (CYTK) | 0.1 | $446k | 9.2k | 48.42 | |
| Morphosys Sponsored Ads (MOR) | 0.1 | $344k | 68k | 5.04 | |
| Biodesix (BDSX) | 0.1 | $165k | 130k | 1.27 | |
| Athenex | 0.0 | $142k | 527k | 0.27 |
